Patents by Inventor Kristin Baldwin

Kristin Baldwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GABOXADOL FOR REDUCING RISK OF SUICIDE AND RAPID RELIEF OF DEPRESSION
    Publication number: 20220054461
    Abstract: Methods and compositions are disclosed for rapidly reducing the risk of suicide in patients suffering from acute suicidality and rapidly relieving mood symptoms in major depression and treatment-resistant depression using a novel therapeutic regimen comprising a single or intermittent administration of a high dose of gaboxadol, or a pharmaceutically acceptable salt thereof, to the subject in need thereof.
    Type: Application
    Filed: April 2, 2021
    Publication date: February 24, 2022
    Applicant: Certego Therapeutics
    Inventors: Pavel Osten, Kristin Baldwin
  • GABOXADOL FOR REDUCING RISK OF SUICIDE AND RAPID RELIEF OF DEPRESSION
    Publication number: 20220008398
    Abstract: Methods and compositions are disclosed for rapidly reducing the risk of suicide in patients suffering from acute suicidality and rapidly relieving mood symptoms in major depression and treatment-resistant depression using a novel therapeutic regimen comprising a single or intermittent administration of a high dose of gaboxadol, or a pharmaceutically acceptable salt thereof, to the subject in need thereof.
    Type: Application
    Filed: November 21, 2019
    Publication date: January 13, 2022
    Inventors: Pavel Osten, Kristin Baldwin
  • Gaboxadol for reducing risk of suicide and rapid relief of depression
    Patent number: 11123332
    Abstract: Methods and compositions are disclosed for rapidly reducing the risk of suicide in patients suffering from acute suicidality and rapidly relieving mood symptoms in major depression and treatment-resistant depression using a novel therapeutic regimen comprising a single or intermittent administration of a high dose of gaboxadol, or a pharmaceutically acceptable salt thereof, to the subject n need thereof.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 21, 2021
    Assignee: Certego Therapeutics Inc.
    Inventors: Pavel Osten, Kristin Baldwin
  • Gaboxadol for reducing risk of suicide and rapid relief of depression
    Patent number: 10966965
    Abstract: Methods and compositions are disclosed for rapidly reducing the risk of suicide in patients suffering from acute suicidality and rapidly relieving mood symptoms in major depression and treatment-resistant depression using a novel therapeutic regimen comprising a single or intermittent administration of a high dose of gaboxadol, or a pharmaceutically acceptable salt thereof, to the subject n need thereof.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: April 6, 2021
    Inventors: Pavel Osten, Kristin Baldwin
  • GABOXADOL FOR REDUCING RISK OF SUICIDE AND RAPID RELIEF OF DEPRESSION
    Publication number: 20200155522
    Abstract: Methods and compositions are disclosed for rapidly reducing the risk of suicide in patients suffering from acute suicidality and rapidly relieving mood symptoms in major depression and treatment-resistant depression using a novel therapeutic regimen comprising a single or intermittent administration of a high dose of gaboxadol, or a pharmaceutically acceptable salt thereof, to the subject n need thereof.
    Type: Application
    Filed: November 21, 2019
    Publication date: May 21, 2020
    Applicant: Certego Therapeutics
    Inventors: Pavel Osten, Kristin Baldwin
  • METHODS AND COMPOSITIONS RELATED TO INDUCED SENSORY NEURONS
    Publication number: 20190276797
    Abstract: This invention provides methods of generating induced sensory neurons (iSNs) from non-neuronal cells such as fibroblasts. The invention also provides methods of using iSNs in various therapeutic or non-therapeutic applications, e.g., methods to identify agents or cellular modulations that enhance iSN formation from non-neuronal cells.
    Type: Application
    Filed: December 26, 2018
    Publication date: September 12, 2019
    Inventors: Joel W. Blanchard, Kevin T. Eade, Kristin Baldwin
  • Methods and compositions related to induced sensory neurons
    Patent number: 10190094
    Abstract: This invention provides methods of generating induced sensory neurons (iSNs) from non-neuronal cells such as fibroblasts. The invention also provides methods of using iSNs in various therapeutic or non-therapeutic applications, e.g., methods to identify agents or cellular modulations that enhance iSN formation from non-neuronal cells.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: January 29, 2019
    Assignee: The Scripps Research Institute
    Inventors: Joel W. Blanchard, Kevin T. Eade, Kristin Baldwin
  • METHODS AND COMPOSITIONS RELATED TO INDUCED SENSORY NEURONS
    Publication number: 20160333311
    Abstract: This invention provides methods of generating induced sensory neurons (iSNs) from non-neuronal cells such as fibroblasts. The invention also provides methods of using iSNs in various therapeutic or non-therapeutic applications, e.g., methods to identify agents or cellular modulations that enhance iSN formation from non-neuronal cells.
    Type: Application
    Filed: December 19, 2014
    Publication date: November 17, 2016
    Inventors: Joel W. Blanchard, Kevin T. Eade, Kristin Baldwin